Citations (198)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Chengkai Zhou, Zhuojia Xu, Gen Li, Qi Gao, Qiang Sui & Tiehai Li. (2021) Efficient synthesis of monophosphoryl lipid A mimetic RC-529. Journal of Carbohydrate Chemistry 40:7-9, pages 501-517.
Read now
Read now
Keye Du, Jia Liu, Ruth Broering, Xiaoyong Zhang, Dongliang Yang, Ulf Dittmer & Mengji Lu. (2018) Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections. Expert Opinion on Drug Discovery 13:7, pages 661-670.
Read now
Read now
Masaud Shah, Muhammad Ayaz Anwar, Jae-Ho Kim & Sangdun Choi. (2016) Advances in Antiviral Therapies Targeting Toll-like Receptors. Expert Opinion on Investigational Drugs 25:4, pages 437-453.
Read now
Read now
Lu Zhang, Wei Wang & Shixia Wang. (2015) Effect of vaccine administration modality on immunogenicity and efficacy. Expert Review of Vaccines 14:11, pages 1509-1523.
Read now
Read now
Jing Hu, Liying Qiu, Xiaoli Wang, Xiaopeng Zou, Mengji Lu & Jian Yin. (2015) Carbohydrate-based vaccine adjuvants – discovery and development. Expert Opinion on Drug Discovery 10:10, pages 1133-1144.
Read now
Read now
Gregory C Ireton & Steven G Reed. (2013) Adjuvants containing natural and synthetic Toll-like receptor 4 ligands. Expert Review of Vaccines 12:7, pages 793-807.
Read now
Read now
Erika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont , Wolf Hervé Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel & Guido Kroemer. (2012) Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. OncoImmunology 1:6, pages 894-907.
Read now
Read now
Xiaoyong Zhang, Anke Kraft, Ruth Broering, Joerg F Schlaak, Ulf Dittmer & Mengji Lu. (2012) Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Expert Opinion on Drug Discovery 7:7, pages 597-611.
Read now
Read now
Manmohan Singh, Jina Kazzaz, Mildred Ugozzoli, Barbara Baudner, Mariagrazia Pizza, Marzia Giuliani, Lynn D. Hawkins, Gillis Otten & Derek T. O’Hagan. (2012) MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine. Human Vaccines & Immunotherapeutics 8:4, pages 486-490.
Read now
Read now
Tino F. Schwarz, Marek Spaczynski, Achim Schneider, Jacek Wysocki, Andrzej Galaj, Karin Schulze, Sylviane M. Poncelet, Gregory Catteau, Florence Thomas & Dominique Descamps. (2011) Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years. Human Vaccines 7:9, pages 958-965.
Read now
Read now
Holly Sanders & Ian M Feavers. (2011) Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Review of Vaccines 10:3, pages 323-334.
Read now
Read now
Jiri Beran. (2008) Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. Expert Opinion on Biological Therapy 8:2, pages 235-247.
Read now
Read now
Sally T Ishizaka & Lynn D Hawkins. (2007) E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Expert Review of Vaccines 6:5, pages 773-784.
Read now
Read now
Yechiel Becker. (2007) Past, present and future of RSV and PIV vaccines and anti-RSV antibodies for the protection of humans against RSV. Expert Opinion on Therapeutic Patents 17:8, pages 941-953.
Read now
Read now
Clint S Schmidt, W John W Morrow & Nadeem A Sheikh. (2007) Smart adjuvants. Expert Review of Vaccines 6:3, pages 391-400.
Read now
Read now
Tino F Schwarz. (2007) Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer. Expert Review of Obstetrics & Gynecology 2:3, pages 293-303.
Read now
Read now
Piyush Patel & Anne Marie F Salapatek. (2006) Pollinex® Quattro: a novel and well–tolerated, ultra short–course allergy vaccine. Expert Review of Vaccines 5:5, pages 617-629.
Read now
Read now
Articles from other publishers (181)
Sophia W. Hulbert, Primit Desai, Michael C. Jewett, Matthew P. DeLisa & Asher J. Williams. (2023) Glycovaccinology: The design and engineering of carbohydrate-based vaccine components. Biotechnology Advances 68, pages 108234.
Crossref
Crossref
Juhienah K. Khalaf, Laura S. Bess, Lois M. Walsh, Janine M. Ward, Craig L. Johnson, Mark T. Livesay, Konner J. Jackson, Jay T. Evans, Kendal T. Ryter & Hélène G. Bazin-Lee. (2023) Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists. Journal of Medicinal Chemistry 66:20, pages 13900-13917.
Crossref
Crossref
Yuanyuan Zhang, Yujie Zhang, Yonghong Li, Yuhan Fu, Yuanru Zhao, Wei Zhao, Runqing Li, Yao Xian, Kangsheng Tu, Feng Wu, Cheng Li, Yuzhu Hou & Mingzhen Zhang. (2023) Harnessing Ag2S quantum dots with immune adjuvant for NIR-II fluorescence imaging-guided sonodynamic immunotherapy of colon cancer. Chemical Engineering Journal 474, pages 145685.
Crossref
Crossref
Gang Hu, David J. Varisco, Sayan Das, C. Russell Middaugh, Francesca Gardner, Robert K. Ernst, Wendy L. Picking & William D. Picking. (2023) Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists. Heliyon 9:7, pages e18119.
Crossref
Crossref
Adithyan Jayaraman, Sujatha Srinivasan, Kiran Babu Uppuluri & Santanu Kar Mahapatra. (2023) Unwinding the mechanism of macrophage repolarization potential of Oceanimonas sp. BPMS22-derived protein protease inhibitor through Toll-like receptor 4 against experimental visceral leishmaniasis. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Ananya Ananya, Kaitlyn G. Holden, Zhiling Gu, Dan Nettleton, Surya K. Mallapragada, Michael J. Wannemuehler, Marian L. Kohut & Balaji Narasimhan. (2023) “Just right” combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation. Immunity & Ageing 20:1.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Ning Chen, Yuan Meng, Huixian Zhan & Gang Li. (2023) Identification and Validation of Potential Ferroptosis-Related Genes in Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Medicina 59:2, pages 297.
Crossref
Crossref
Shaswath S. Chandrasekar, Brock A. Kingstad-Bakke, Chia-Wei Wu, Yashdeep Phanse, Jorge E. Osorio & Adel M. Talaat. (2023) A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens. Vaccines 11:2, pages 302.
Crossref
Crossref
Xingyu Heng, Ruyan Feng, Lijuan Zhu, Liyin Yu, Gaojian Chen & Hong Chen. (2022) Dendritic cells maturation facilitated by group-adjustable lipopolysaccharide analogues synthesized via RAFT polymerization. Chinese Chemical Letters 33:9, pages 4331-4334.
Crossref
Crossref
Xujun Cao, Anthony F. Cordova & Lingyin Li. (2021) Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act. Chemical Reviews 122:3, pages 3414-3458.
Crossref
Crossref
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design
179
231
.
Mohammad Enamul Hoque Kayesh, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2021) An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Viruses 13:11, pages 2302.
Crossref
Crossref
Lingqiang Gao, Qinghai Lian, Leilei Ma, Shiwei Su, Menglan Yang, Yuan Fang, Zhongqiu Liu, Xiang Luo & Guochao Liao. (2021) Full synthesis and bioactivity evaluation of Tn-RC-529 derivative conjugates as self-adjuvanting cancer vaccines. Chinese Chemical Letters 32:10, pages 3011-3014.
Crossref
Crossref
Jialing Hu, Jiasheng Xu, Xiaojin Feng, Yiran Li, Fuzhou Hua & Guohai Xu. (2021) Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mousa Komai-Koma, Yuan Ji, Hui Cao, Zhigang Liu, Charles McSharry & Damo Xu. (2021) Monophosphoryl lipid A directly regulates Th1 cytokine production in human CD4+ T-cells through Toll-like receptor 2 and 4. Immunobiology 226:5, pages 152132.
Crossref
Crossref
Despo Chatzikleanthous, Derek T. O’Hagan & Roberto Adamo. (2021) Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Molecular Pharmaceutics 18:8, pages 2867-2888.
Crossref
Crossref
Tayebeh Ghaedi, Parivash Davoodian, Mehdi Hassaniazad, Ebrahim Eftekhar, Sobhan Faezi, Ali Atash Abparvar, Mohammad Ali Einakian & Khadijeh Ahmadi. (2021) Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice. Journal of Immunological Methods 494, pages 113055.
Crossref
Crossref
Ehsan kianfar. (2021) Magnetic Nanoparticles in Targeted Drug Delivery: a Review. Journal of Superconductivity and Novel Magnetism 34:7, pages 1709-1735.
Crossref
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, André Luis Souza dos Santos, Aarthy C Vallur & Maria do Socorro Pires e Cruz. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases
29
46
.
Koichi Fukase. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
166
184
.
Yi-Qi Wang, Hélène Bazin-Lee, Jay T. Evans, Carolyn R. Casella & Thomas C. Mitchell. (2020) MPL Adjuvant Contains Competitive Antagonists of Human TLR4. Frontiers in Immunology 11.
Crossref
Crossref
Nayan Gupta & Ajay Kumar. (2020) Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach. Microbial Pathogenesis 147, pages 104398.
Crossref
Crossref
Shuyao Lang & Xuefei Huang. (2020) Carbohydrate Conjugates in Vaccine Developments. Frontiers in Chemistry 8.
Crossref
Crossref
Marcelo Vivolo Aun, Francine Maria de Almeida, Beatriz Mangueira Saraiva-Romanholo, Mílton de Arruda Martins, Jorge Kalil, Fernanda Magalhães Arantes-Costa & Pedro Giavina-Bianchi. (2020) Diphteria-tetanus-pertussis vaccine reduces specific IgE, inflammation and remodelling in an animal model of mite-induced respiratory allergy. Vaccine 38:1, pages 70-78.
Crossref
Crossref
A. M. V. N. Prathyusha, Prudhvi Lal Bhukya & Pallaval Veera Bramhachari. 2020. Dynamics of Immune Activation in Viral Diseases. Dynamics of Immune Activation in Viral Diseases
149
159
.
Kristopher K. Short, Shannon M. Miller, Lois Walsh, Van Cybulski, Hélène Bazin, Jay T. Evans & David Burkhart. (2019) Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity. Journal of Controlled Release 315, pages 186-196.
Crossref
Crossref
Paul Baldrick, James W. Hutchings, Matthew D. Heath & Murray A. Skinner. (2019) Safety Evaluation of PQ Birch Allergy Immunotherapy to Support Product Development. Regulatory Toxicology and Pharmacology 108, pages 104441.
Crossref
Crossref
Paul Baldrick, James W. Hutchings, Matthew D. Heath, Murray A. Skinner, Tom Martin & Chris Gray. (2019) New toxicity testing of PQ grass allergy immunotherapy to support product development. Journal of Applied Toxicology 39:10, pages 1462-1469.
Crossref
Crossref
Rebecca S. Rudicell, Marie Garinot, Masaru Kanekiyo, Heather D. Kamp, Kurt Swanson, Te-hui Chou, Shujia Dai, Olivier Bedel, Daniel Simard, Rebecca A. Gillespie, Kanwen Yang, Michael Reardon, Luis Z. Avila, Magnus Besev, Pradeep K. Dhal, Ram Dharanipragada, Lingyi Zheng, Xiaochu Duan, Joshua Dinapoli, Thorsten U. Vogel, Harry Kleanthous, John R. Mascola, Barney S. Graham, Jean Haensler, Chih-Jen Wei & Gary J. Nabel. (2019) Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine 37:42, pages 6208-6220.
Crossref
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, Rebecca Tavares Lima & Maria do Socorro Pires e Cruz. (2019) Novos adjuvantes vacinais: importante ferramenta para imunoterapia da leishmaniose visceral. HU Revista 44:3, pages 401-410.
Crossref
Crossref
Emiliano Manzo, Carmela Gallo, Laura Fioretto, Genoveffa Nuzzo, Giusi Barra, Dario Pagano, Irene Russo Krauss, Luigi Paduano, Marcello Ziaco, Marina DellaGreca, Raffaele De Palma & Angelo Fontana. (2019) Diasteroselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant. ACS Omega 4:4, pages 7807-7814.
Crossref
Crossref
Zahra Sepehri, Zohre Kiani, Farhad Kohan & Saeid Ghavami. (2019)
Toll-Like Receptor 4 as an Immune Receptor Against
Mycobacterium tuberculosis
: A Systematic Review
. Laboratory Medicine 50:2, pages 117-129.
Crossref
Crossref
Caroline C. Krueger, Franziska Thoms, Elsbeth Keller, Fabiana M. S. Leoratti, Monique Vogel & Martin F. Bachmann. (2019) RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion. Frontiers in Immunology 10.
Crossref
Crossref
Kritika Gupta, Marianne Saldanha, Mruganka Parasnis, Padma V. Devarajan, Ratnesh Jain & Prajakta Dandekar. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
323
349
.
Soghra Hesam, Baharak Khoshkholgh-Sima, Hamid Gholami Pourbadie, Vahab Babapour, Morteza Zendedel & Mohammad Sayyah. (2018) Monophosphoryl Lipid A and Pam3Cys Prevent the Increase in Seizure Susceptibility and Epileptogenesis in Rats Undergoing Traumatic Brain Injury. Neurochemical Research 43:10, pages 1978-1985.
Crossref
Crossref
Wei Dong, Yoshita Bhide, Sonny Marsman, Marijke Holtrop, Tjarko Meijerhof, Jacqueline de Vries-Idema, Aalzen de Haan & Anke Huckriede. (2018) Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. Biotechnology Journal 13:4, pages 1700645.
Crossref
Crossref
Roberta Olmo Pinheiro, Veronica Schmitz, Bruno Jorge de Andrade Silva, André Alves Dias, Beatriz Junqueira de Souza, Mayara Garcia de Mattos Barbosa, Danuza de Almeida Esquenazi, Maria Cristina Vidal Pessolani & Euzenir Nunes Sarno. (2018) Innate Immune Responses in Leprosy. Frontiers in Immunology 9.
Crossref
Crossref
Anneliese S. Ashhurst, Thaigarajan Parumasivam, John Gar Yan Chan, Leon C. W. Lin, Manuela Flórido, Nicholas P. West, Hak-Kim Chan & Warwick J. Britton. (2018) PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection. PLOS ONE 13:3, pages e0194620.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerDennis M. Klinman & Hidekazu Shirota. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
143
174
.
Kelsey A. Gregg, Erin Harberts, Francesca M. Gardner, Mark R. Pelletier, Corinne Cayatte, Li Yu, Michael P. McCarthy, Jason D. Marshall & Robert K. Ernst. (2017) Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery. mBio 8:3.
Crossref
Crossref
Pankajini Mallick, Sumit Basu, Bhagavtula Moorthy & Romi Ghose. (2017) Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. Toxicology in Vitro 41, pages 75-82.
Crossref
Crossref
Zahra Sepehri, Zohre Kiani, Farhad Kohan, Seyed Moayed Alavian & Saeid Ghavami. (2017) Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sciences 179, pages 80-87.
Crossref
Crossref
Taro Iwasaki, Takashi Hirano, Satoru Kodama, Yoshinori Kadowaki, Munehito Moriyama, Toshiaki Kawano & Masashi Suzuki. (2017) Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization. International Journal of Pediatric Otorhinolaryngology 97, pages 5-12.
Crossref
Crossref
Reza Nosratababadi, Vahid Bagheri, Mohammad Zare-Bidaki, Hamid Hakimi, Nahid Zainodini & Mohammad Kazemi Arababadi. (2017) Toll like receptor 4: an important molecule in recognition and induction of appropriate immune responses against Chlamydia infection. Comparative Immunology, Microbiology and Infectious Diseases 51, pages 27-33.
Crossref
Crossref
Ji Ung KimMiyeon KimSinae KimTam Thanh NguyenEunhye KimSiyoung LeeSoohyun KimHyunwoo Kim. (2017) Dendritic Cell Dysfunction in Patients with End-stage Renal Disease. Immune Network 17:3, pages 152.
Crossref
Crossref
Tae-Young Lee, Chang-Ung Kim, Eun-Hye Bae, Sang-Hwan Seo, Dae Gwin Jeong, Sun-Woo Yoon, Kyu-Tae Chang, Young Sang Kim, Sang-Hyun Kim & Doo-Jin Kim. (2017) Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model. Vaccine 35:4, pages 586-595.
Crossref
Crossref
A.M. Didierlaurent, A. Berger, T.C. Heineman, V. Henderickx, F. Tavares Da Silva, J. Vekemans, G. Voss & N. Garçon. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
265
285
.
Antonio Hernandez, Julia K Bohannon, Liming Luan, Benjamin A Fensterheim, Yin Guo, Naeem K Patil, Chase McAdams, Jingbin Wang & Edward R Sherwood. (2016) The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes. Journal of Leukocyte Biology 100:6, pages 1311-1322.
Crossref
Crossref
Sanjay Varikuti, Steve Oghumu, Gayathri Natarajan, Jennifer Kimble, Rachel H Sperling, Ellen Moretti, Mark H Kaplan & Abhay R Satoskar. (2016) STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity. International Immunology 28:11, pages 565-570.
Crossref
Crossref
Amin Afsharimoghaddam, Mohammad Soleimani, Alireza Lashay, Mahdi Dehghani & Zahra Sepehri. (2016) Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review. Life Sciences 158, pages 31-36.
Crossref
Crossref
Sonja T. H. M. Kolanowski, Suzanne N. Lissenberg-Thunnissen, Diba Emal, S. Marieke van Ham & Anja ten Brinke. (2016) Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells. Inflammation Research 65:6, pages 449-458.
Crossref
Crossref
Mohammad Amin BehzadiAbdolvahab AlborziMehdi KalaniGholamreza PouladfarMehdi DianatpourMazyar Ziyaeyan. (2016) Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice. Viral Immunology 29:3, pages 138-147.
Crossref
Crossref
Sigridur Jonsdottir, Vilhjalmur Svansson, Sara Bjork Stefansdottir, Gertraud Schüpbach, Claudio Rhyner, Eliane Marti & Sigurbjorg Torsteinsdottir. (2016) A preventive immunization approach against insect bite hypersensitivity: Intralymphatic injection with recombinant allergens in Alum or Alum and monophosphoryl lipid A. Veterinary Immunology and Immunopathology 172, pages 14-20.
Crossref
Crossref
Shu-Ling Fu, Chun-Cheng Lin, Ming-Ling Hsu, Sheng-Hung Liu, Yu-Chuen Huang & Yu-Jen Chen. (2016) CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells. Oncotarget 7:10, pages 11677-11686.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
145
163
.
Fred Zepp. 2016. Vaccine Design. Vaccine Design
57
84
.
Se-hee Moon, Eui-Cheol Shin, Young-Woock Noh & Yong Taik Lim. (2015) Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine. Vaccine 33:38, pages 4762-4769.
Crossref
Crossref
M. Radman, A. Golshiri, A. Shamsizadeh, N. Zainodini, V. Bagheri, M.K. Arababadi & D. Kennedy. (2015) Toll-like receptor 4 plays significant roles during allergic rhinitis. Allergologia et Immunopathologia 43:4, pages 416-420.
Crossref
Crossref
Jean Haensler, Patricia Probeck, Jin Su, Fabienne Piras, François Dalençon, Jean-François Cotte, Véronique Chambon, Shehzad M. Iqbal, Lynn Hawkins & Nicolas Burdin. (2015) Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. International Journal of Pharmaceutics 486:1-2, pages 99-111.
Crossref
Crossref
Ejuan Zhang & Mengji Lu. (2014) Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Medical Microbiology and Immunology 204:1, pages 11-20.
Crossref
Crossref
D. L. F. Portuondo, L. S. Ferreira, A. C. Urbaczek, A. Batista-Duharte & I. Z. Carlos. (2014) Adjuvants and delivery systems for antifungal vaccines: Current state and future developments. Medical Mycology 53:1, pages 69-89.
Crossref
Crossref
Zhenhua Li, Kai Dong, Yan Zhang, Enguo Ju, Zhaowei Chen, Jinsong Ren & Xiaogang Qu. (2015) Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response. Chemical Communications 51:88, pages 15975-15978.
Crossref
Crossref
Joseph P. KolbCarolyn R. CasellaShuvasree SenGuptaPaula M. ChiltonThomas C. Mitchell. (2014) Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. Science Signaling 7:351.
Crossref
Crossref
Mira C Patel, Kari Ann Shirey, Lioubov M Pletneva, Marina S Boukhvalova, Alfredo Garzino-Demo, Stefanie N Vogel & Jorge CG Blanco. (2014) Novel drugs targeting Toll-like receptors for antiviral therapy. Future Virology 9:9, pages 811-829.
Crossref
Crossref
Mohammad Zare-BidakiKyoko Tsukiyama-KoharaMohammad Kazemi Arababadi. (2014) Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis. Viral Immunology 27:7, pages 321-326.
Crossref
Crossref
Dhanusha Yesudhas, Vijayakumar Gosu, Muhammad Ayaz Anwar & Sangdun Choi. (2014) Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer. Frontiers in Immunology 5.
Crossref
Crossref
Yingying Xu, Pak-Wai Yuen & Jenny Lam. (2014) Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. Pharmaceutics 6:3, pages 378-415.
Crossref
Crossref
Johan M. J. Van den Bergh, Khadija Guerti, Yannick Willemen, Eva Lion, Nathalie Cools, Herman Goossens, Alex Vorsters, Viggo F. I. Van Tendeloo, Sébastien Anguille, Pierre Van Damme & Evelien L. J. M. Smits. (2014)
HPV
vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against
HPV
‐positive tumour cells
. Journal of Cellular and Molecular Medicine 18:7, pages 1372-1380.
Crossref
Crossref
Joseph P. Nkolola, Ann Cheung, James R. Perry, Darrick Carter, Steve Reed, Hanneke Schuitemaker, Maria Grazia Pau, Michael S. Seaman, Bing Chen & Dan H. Barouch. (2014) Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer. Vaccine 32:18, pages 2109-2116.
Crossref
Crossref
Mohammad Zare-Bidaki, Hamid Hakimi, Seyyed Hossein Abdollahi, Nahid Zainodini, Mohammad Kazemi Arababadi & Derek Kennedy. (2014) TLR4 in Toxoplasmosis; friends or foe?. Microbial Pathogenesis 69-70, pages 28-32.
Crossref
Crossref
Agrinaldo Nascimento, Frederico J. S. Pontes, Roberto D. Lins & Thereza A. Soares. (2014) Hydration, ionic valence and cross-linking propensities of cations determine the stability of lipopolysaccharide (LPS) membranes. Chem. Commun. 50:2, pages 231-233.
Crossref
Crossref
Ying-Chyi Song, Han-Yin Cheng, Chih-Hsiang Leng, Sheng-Kuo Chiang, Chih-Wei Lin, Pele Chong, Ming-Hsi Huang & Shih-Jen Liu. (2014) A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity. Journal of Controlled Release 173, pages 158-165.
Crossref
Crossref
Jesús Arenas. 2014. Molecular Vaccines. Molecular Vaccines
527
536
.
Xiaobo Hu, Rui Liu & Naishuo Zhu. (2013) Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice. Immunobiology 218:12, pages 1524-1528.
Crossref
Crossref
Lynette Denny, Bronwyn Hendricks, Chivaugn Gordon, Florence Thomas, Marjan Hezareh, Kurt Dobbelaere, Christelle Durand, Caroline Hervé & Dominique Descamps. (2013) Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study. Vaccine 31:48, pages 5745-5753.
Crossref
Crossref
Tejinder Kaur, Ankita Thakur & Sukhbir Kaur. (2012) Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis. Journal of Parasitic Diseases 37:2, pages 231-239.
Crossref
Crossref
L. Martínez-Gil, P. H. Goff, R. Hai, A. García-Sastre, M. L. Shaw & P. Palese. (2013) A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant. Journal of Virology 87:3, pages 1290-1300.
Crossref
Crossref
Yaning Han, Ye Li, Jiuzhou Chen, Yanzhen Tan, Feng Guan & Xiaoyuan Wang. (2013) Construction of Monophosphoryl Lipid A Producing Escherichia coli Mutants and Comparison of Immuno-Stimulatory Activities of Their Lipopolysaccharides. Marine Drugs 11:12, pages 363-376.
Crossref
Crossref
Maria Pihlgren, Alberto B. Silva, Rime Madani, Valérie Giriens, Ying Waeckerle-Men, Antonia Fettelschoss, David T. Hickman, María Pilar López-Deber, Dorin Mlaki Ndao, Marija Vukicevic, Anna Lucia Buccarello, Valérie Gafner, Nathalie Chuard, Pedro Reis, Kasia Piorkowska, Andrea Pfeifer, Thomas M. Kündig, Andreas Muhs & Pål Johansen. (2013) TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice. Blood 121:1, pages 85-94.
Crossref
Crossref
Babak Jalilian, Stig Hill Christiansen, Halldór Bjarki Einarsson, Mehdi Rasoli Pirozyan, Eskild Petersen & Thomas Vorup-Jensen. (2013) Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?. Molecular and Cellular Therapies 1:1, pages 2.
Crossref
Crossref
Ankur Singh, Pallab Pradhan & Krishnendu Roy. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
161
181
.
Darren R. Flower. 2013. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines
155
180
.
Yasuyuki Goto & Steven G. Reed. 2012. Immunity to Parasitic Infection. Immunity to Parasitic Infection
431
440
.
Heather L. Wilson, Scott Napper, George K. Mutwiri, Sylvia van Drunen Littel‐van den Hurk, Hugh Townsend, Lorne A. Babiuk, Andrew A. Potter & Volker Gerdts. 2012. Vaccinology. Vaccinology
13
28
.
Ji Eun Han, Seo Ri Wui, Shin Ae Park, Na Gyong Lee, Kwang Sung Kim, Yang Je Cho, Hyoung Jin Kim & Hong-Jin Kim. (2012) Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice. Vaccine 30:28, pages 4127-4134.
Crossref
Crossref
Joanne M. Lumsden, Saule Nurmukhambetova, Jennifer H. Klein, Jetsumon Sattabongkot, Jason W. Bennett, Sylvie Bertholet, Christopher B. Fox, Steven G. Reed, Christian F. Ockenhouse, Randall F. Howard, Mark E. Polhemus & Anjali Yadava. (2012) Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice. Vaccine 30:22, pages 3311-3319.
Crossref
Crossref
Yang Yang, Eliver Eid Bou Ghosn, Leah E. Cole, Tetyana V. Obukhanych, Patricia Sadate-Ngatchou, Stefanie N. Vogel, Leonard A. Herzenberg & Leonore A. Herzenberg. (2012) Antigen-specific antibody responses in B-1a and their relationship to natural immunity. Proceedings of the National Academy of Sciences 109:14, pages 5382-5387.
Crossref
Crossref
Liang Xiao, Jocelyn Kim, Matthew Lim, Bingbing Dai, Lili Yang, Steven G. Reed, David Baltimore & Pin Wang. (2012) A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine 30:15, pages 2570-2581.
Crossref
Crossref
Mona Hedayat, Kiyoshi Takeda & Nima Rezaei. (2010) Prophylactic and therapeutic implications of toll‐like receptor ligands. Medicinal Research Reviews 32:2, pages 294-325.
Crossref
Crossref
Matteo Piazza, Valentina Calabrese, Gaetana Damore, Roberto Cighetti, Theresa Gioannini, Jerrold Weiss & Francesco Peri. (2012) A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity. ChemMedChem 7:2, pages 213-217.
Crossref
Crossref
Steven R. Little. (2012) Reorienting our view of particle-based adjuvants for subunit vaccines. Proceedings of the National Academy of Sciences 109:4, pages 999-1000.
Crossref
Crossref
Fatima K. Ahmed, Brenda E. Clark, Dennis R. Burton & Ralph Pantophlet. (2012) An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site. Vaccine 30:5, pages 922-930.
Crossref
Crossref
Arnaud Wilmar, Caroline Lonez, Marjorie Vermeersch, Mathieu Andrianne, David Pérez-Morga, Jean-Marie Ruysschaert, Michel Vandenbranden, Oberdan Leo & Stéphane T. Temmerman. (2012) The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism. Vaccine 30:2, pages 414-424.
Crossref
Crossref
Francesco Peri, Valentina Calabrese, Matteo Piazza & Roberto Cighetti. (2011) Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: A new generation of immunotherapeutics. Pure and Applied Chemistry 84:1, pages 97-106.
Crossref
Crossref
Takashi Hirano, Satoru Kodama, Toshiaki Kawano, Kazuhiko Maeda & Masashi Suzuki. (2011)
Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable
Haemophilus influenzae
and
Moraxella catarrhalis
from the nasopharynx in mice
. FEMS Immunology & Medical Microbiology 63:3, pages 407-417.
Crossref
Crossref
Johan Mattsson, Ulf Yrlid, Anneli Stensson, Karin Schön, Mikael C. I. Karlsson, Jeffrey V. Ravetch & Nils Y. Lycke. (2011) Complement Activation and Complement Receptors on Follicular Dendritic Cells Are Critical for the Function of a Targeted Adjuvant. The Journal of Immunology 187:7, pages 3641-3652.
Crossref
Crossref
Tomofumi Uto, Takami Akagi, Masaaki Toyama, Yosuke Nishi, Fumiaki Shima, Mitsuru Akashi & Masanori Baba. (2011) Comparative activity of biodegradable nanoparticles with aluminum adjuvants: Antigen uptake by dendritic cells and induction of immune response in mice. Immunology Letters 140:1-2, pages 36-43.
Crossref
Crossref
Marc Mueller, Eva Schlosser, Bruno Gander & Marcus Groettrup. (2011) Tumor eradication by immunotherapy with biodegradable PLGA microspheres—an alternative to incomplete Freund's adjuvant. International Journal of Cancer 129:2, pages 407-416.
Crossref
Crossref
Leah E Cole, Barbara J Mann, Kari Ann Shirey, Katharina Richard, Yang Yang, Patricia J Gearhart, Kirsty L Chesko, Rose M Viscardi & Stefanie N Vogel. (2011)
Role of TLR signaling in
Francisella tularensis
-LPS-induced, antibody-mediated protection against
Francisella tularensis
challenge
. Journal of Leukocyte Biology 90:4, pages 787-797.
Crossref
Crossref
Qingke Kong, David A. Six, Kenneth L. Roland, Qing Liu, Lillian Gu, C. Michael Reynolds, Xiaoyuan Wang, Christian R. H. Raetz & Roy CurtissIIIIII. (2011)
Salmonella
Synthesizing 1-Monophosphorylated Lipopolysaccharide Exhibits Low Endotoxic Activity while Retaining Its Immunogenicity
. The Journal of Immunology 187:1, pages 412-423.
Crossref
Crossref
Caglar Cekic, Carolyn R. Casella, Duygu Sag, Frann Antignano, Joseph Kolb, Jill Suttles, Michael R. Hughes, Gerald Krystal & Thomas C. Mitchell. (2011) MyD88-Dependent SHIP1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR4. The Journal of Immunology 186:7, pages 3858-3865.
Crossref
Crossref
Folkert Steinhagen, Takeshi Kinjo, Christian Bode & Dennis M. Klinman. (2011) TLR-based immune adjuvants. Vaccine 29:17, pages 3341-3355.
Crossref
Crossref
W Tai, L Roberts, A Seryshev, J M Gubatan, C S Bland, R Zabriskie, S Kulkarni, L Soong, I Mbawuike, B Gilbert, F Kheradmand & D B Corry. (2011) Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic. Mucosal Immunology 4:2, pages 197-207.
Crossref
Crossref
Pernille Nordly, Else Marie Agger, Peter Andersen, Hanne Mørck Nielsen & Camilla Foged. (2010) Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo. Pharmaceutical Research 28:3, pages 553-562.
Crossref
Crossref
Lawrence Segal, Owen K. Wilby, Chris R. Willoughby, Stéphane Veenstra & Marguerite Deschamps. (2011) Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in rats. Reproductive Toxicology 31:1, pages 111-120.
Crossref
Crossref
Francesco Peri, Matteo Piazza, Valentina Calabrese & Roberto Cighetti. 2011. Bacterial Lipopolysaccharides. Bacterial Lipopolysaccharides
389
416
.
Aniruddha Roy, Manu Smriti Singh, Pramod Upadhyay & Sangeeta Bhaskar. (2010) Combined Chemo-immunotherapy as a Prospective Strategy To Combat Cancer: A Nanoparticle Based Approach. Molecular Pharmaceutics 7:5, pages 1778-1788.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Yu-Qian Zhang, Ya-Chea Tsai, Archana Monie, Chien-Fu Hung & T.-C. Wu. (2010) Carrageenan as an adjuvant to enhance peptide-based vaccine potency. Vaccine 28:32, pages 5212-5219.
Crossref
Crossref
T. Trotta, A. Fasanella, D. Scaltrito, L. Gradoni, V. Mitolo, O. Brandonisio, A. Acquafredda & M.A. Panaro. (2010) Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability. Comparative Immunology, Microbiology and Infectious Diseases 33:2, pages 175-182.
Crossref
Crossref
Yinyao Lin, Samantha R. Slight & Shabaana A. Khader. (2010) Th17 cytokines and vaccine-induced immunity. Seminars in Immunopathology 32:1, pages 79-90.
Crossref
Crossref
Amandine Legat, Séverine Thomas, Philippe Hermand, Marcelle Van Mechelen, Michel Goldman & Dominique De Wit. (2010) CD14‐independent responses induced by a synthetic lipid A mimetic. European Journal of Immunology 40:3, pages 797-802.
Crossref
Crossref
Murielle Surquin, Christian L. Tielemans, Imre Kulcsár, Miroslav Ryba, Péter Vörös, Olivier Mat, Serge Treille, Michel Dhaene, Jean-Claude Stolear, Sherine O. Kuriyakose, Maarten X. Leyssen & Sophie A. Houard. (2010) Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine. Kidney International 77:3, pages 247-255.
Crossref
Crossref
Qianli Wang & Zhongwu Guo. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II
91
122
.
Christopher B. Fox, Martin Friede, Steven G. Reed & Gregory C. Ireton. 2010. Endotoxins: Structure, Function and Recognition. Endotoxins: Structure, Function and Recognition
303
321
.
Jean Haensler. 2010. Vaccine Adjuvants. Vaccine Adjuvants
73
90
.
Kaustabh K. Maiti, Michael DeCastro, Abu‐Baker M. Abdel‐Aal El‐Sayed, Matthew I. Foote, Margreet A. Wolfert & Geert‐Jan Boons. (2009) Chemical Synthesis and Proinflammatory Responses of Monophosphoryl Lipid A Adjuvant Candidates. European Journal of Organic Chemistry 2010:1, pages 80-91.
Crossref
Crossref
Dennis Christensen, Karen Korsholm, Grith Krøyer Wood, Afzal Mohammed, Vincent Bramwell, Peter Andersen, Else Marie Agger & Yvonne Perrie. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
357
376
.
Arnaud M. Didierlaurent, Sandra Morel, Laurence Lockman, Sandra L. Giannini, Michel Bisteau, Harald Carlsen, Anders Kielland, Olivier Vosters, Nathalie Vanderheyde, Francesca Schiavetti, Daniel Larocque, Marcelle Van Mechelen & Nathalie Garçon. (2009) AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity. The Journal of Immunology 183:10, pages 6186-6197.
Crossref
Crossref
Caglar Cekic, Carolyn R. Casella, Chelsea A. Eaves, Atsushi Matsuzawa, Hidenori Ichijo & Thomas C. Mitchell. (2009) Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A. Journal of Biological Chemistry 284:46, pages 31982-31991.
Crossref
Crossref
Sylvie Bertholet, Yasuyuki Goto, Lauren Carter, Ajay Bhatia, Randall F. Howard, Darrick Carter, Rhea N. Coler, Thomas S. Vedvick & Steven G. Reed. (2009) Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine 27:50, pages 7036-7045.
Crossref
Crossref
Jayalakshmi Krishnan, Gwang Lee & Sangdun Choi. (2009) Drugs targeting toll-like receptors. Archives of Pharmacal Research 32:11.
Crossref
Crossref
R. N. COLER, D. CARTER, M. FRIEDE & S. G. REED. (2009) Adjuvants for malaria vaccines. Parasite Immunology 31:9, pages 520-528.
Crossref
Crossref
R. B. Mandell, R. Flick, W. R. Staplin, L. D. Kaniewski, A. K. Carzoli, R. P. Manuszak, J. Wang, G. R. Rossi, N. N. Vahanian & C. J. Link. (2009)
The αGal HyperAcute
®
Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal‐Mediated Zoonotic Blockade
. Zoonoses and Public Health 56:6-7, pages 391-406.
Crossref
Crossref
Constance M. John, Mingfeng Liu & Gary A. Jarvis. (2009) Natural Phosphoryl and Acyl Variants of Lipid A from Neisseria meningitidis Strain 89I Differentially Induce Tumor Necrosis Factor-α in Human Monocytes. Journal of Biological Chemistry 284:32, pages 21515-21525.
Crossref
Crossref
E G Rhee & D H Barouch. (2009) Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development. Clinical and Experimental Immunology 157:2, pages 174-180.
Crossref
Crossref
Alison M. Daines, Ben W. Greatrex, Colin M. Hayman, Sarah M. Hook, Warren T. McBurney, Thomas Rades, Phillip M. Rendle & Ian M. Sims. (2009) Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems. Bioorganic & Medicinal Chemistry 17:14, pages 5207-5218.
Crossref
Crossref
Barbara C. Baudner, Vanessa Ronconi, Daniele Casini, Marco Tortoli, Jina Kazzaz, Manmohan Singh, Lynn D. Hawkins, Andreas Wack & Derek T. O’Hagan. (2009) MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020). Pharmaceutical Research 26:6, pages 1477-1485.
Crossref
Crossref
Néjia Sassi, Catherine Paul, Amandine Martin, Ali Bettaieb & Jean-François Jeannin. 2010. Lipid A in Cancer Therapy. Lipid A in Cancer Therapy
69
80
.
Christopher W. Cluff. 2010. Lipid A in Cancer Therapy. Lipid A in Cancer Therapy
111
123
.
Cevayir Coban, Ken J. Ishii & Shizuo Akira. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
63
80
.
Istvan Toth, Pavla Simerska & Yoshio Fujita. (2008) Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines. International Journal of Peptide Research and Therapeutics 14:4, pages 333-340.
Crossref
Crossref
J. Song & S. N. Abraham. (2008) Innate and adaptive immune responses in the urinary tract. European Journal of Clinical Investigation 38:s2, pages 21-28.
Crossref
Crossref
Weihsu Chen, Weili Yan & Leaf Huang. (2007) A simple but effective cancer vaccine consisting of an antigen and a cationic lipid. Cancer Immunology, Immunotherapy 57:4, pages 517-530.
Crossref
Crossref
Pascal Mettens, Patrice M. Dubois, Marie-Ange Demoitié, Babak Bayat, Marie-Noëlle Donner, Patricia Bourguignon, V. Ann Stewart, D. Gray HeppnerJr.Jr., Nathalie Garçon & Joe Cohen. (2008) Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine 26:8, pages 1072-1082.
Crossref
Crossref
Frederick R. Vogel & Stanley L. Hem. 2008. Vaccines. Vaccines
59
71
.
Ken J. Ishii & Shizuo Akira. 2008. Clinical Immunology. Clinical Immunology
39
51
.
Floris Fransen, Claire J. Boog, Jos P. van Putten & Peter van der Ley. (2007)
Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine against
Neisseria meningitidis
Serogroup B
. Infection and Immunity 75:12, pages 5939-5946.
Crossref
Crossref
Joanne Lysaght, Andrew G. Jarnicki & Kingston H. G. Mills. (2007) Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity. Cancer Immunology, Immunotherapy 56:9, pages 1367-1379.
Crossref
Crossref
Samar Hamdy, Azita Haddadi, Vishwa Somayaji, David Ruan & John Samuel. (2007) Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (d,l-lactic-co-glycolic acid) nanoparticle formulations. Journal of Pharmaceutical and Biomedical Analysis 44:4, pages 914-923.
Crossref
Crossref
Jeroen Geurtsen, H. Alexander Banus, Eric R. Gremmer, Henke Ferguson, Liset J. J. de la Fonteyne-Blankestijn, Jolanda P. Vermeulen, Jan A. M. A. Dormans, Jan Tommassen, Peter van der Ley, Frits R. Mooi & Rob J. Vandebriel. (2007) Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice. Clinical and Vaccine Immunology 14:7, pages 821-829.
Crossref
Crossref
Ken J. Ishii & Shizuo Akira. (2007) Toll or Toll-Free Adjuvant Path Toward the Optimal Vaccine Development. Journal of Clinical Immunology 27:4, pages 363-371.
Crossref
Crossref
Verónica Mata-HaroCaglar CekicMichael MartinPaula M. ChiltonCarolyn R. CasellaThomas C. Mitchell. (2007) The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4. Science 316:5831, pages 1628-1632.
Crossref
Crossref
Samar Hamdy, Praveen Elamanchili, Aws Alshamsan, Ommoleila Molavi, Tadaaki Satou & John Samuel. (2007) Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. Journal of Biomedical Materials Research Part A 81A:3, pages 652-662.
Crossref
Crossref
Praveen Elamanchili, Christine M. E. Lutsiak, Samar Hamdy, Manish Diwan & John Samuel. (2007) “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells. Journal of Immunotherapy 30:4, pages 378-395.
Crossref
Crossref
Holger Kanzler, Franck J Barrat, Edith M Hessel & Robert L Coffman. (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Medicine 13:5, pages 552-559.
Crossref
Crossref
Zi-Hua Jiang, Wladyslaw A. Budzynski, Dongxu Qiu, Damayanthi Yalamati & R. Rao Koganty. (2007) Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity. Carbohydrate Research 342:6, pages 784-796.
Crossref
Crossref
Shabaana A Khader, Guy K Bell, John E Pearl, Jeffrey J Fountain, Javier Rangel-Moreno, Garth E Cilley, Fang Shen, Sheri M Eaton, Sarah L Gaffen, Susan L Swain, Richard M Locksley, Laura Haynes, Troy D Randall & Andrea M Cooper. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology 8:4, pages 369-377.
Crossref
Crossref
Christiana N. Fogg, Jeffrey L. Americo, Shlomo Lustig, John W. Huggins, Scott K. Smith, Inger Damon, Wolfgang Resch, Patricia L. Earl, Dennis M. Klinman & Bernard Moss. (2007) Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges. Vaccine 25:15, pages 2787-2799.
Crossref
Crossref
Lakshmi Krishnan, Komal Gurnani, Chantal J. Dicaire, Henk van Faassen, Ahmed Zafer, Carsten J. Kirschning, Subash Sad & G. Dennis Sprott. (2007) Rapid Clonal Expansion and Prolonged Maintenance of Memory CD8+ T Cells of the Effector (CD44highCD62Llow) and Central (CD44highCD62Lhigh) Phenotype by an Archaeosome Adjuvant Independent of TLR2. The Journal of Immunology 178:4, pages 2396-2406.
Crossref
Crossref
Jun Kunisawa, Jerry R. McGhee & Hiroshi Kiyono. 2007. Mucosal Immune Defense: Immunoglobulin A. Mucosal Immune Defense: Immunoglobulin A
345
389
.
Jian Wu & Zhongwu Guo. (2006) Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines. Bioconjugate Chemistry 17:6, pages 1537-1544.
Crossref
Crossref
Sabine Hoffjan & Jörg T. Epplen. (2006) Toll-like receptors and airway disease. Drug Discovery Today: Therapeutic Strategies 3:3, pages 317-324.
Crossref
Crossref
Ofer LevyEugénie E. SuterRichard L. MillerMichael R. Wessels. (2006) Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 108:4, pages 1284-1290.
Crossref
Crossref
Karen Zaks, Michael Jordan, Amanda Guth, Karen Sellins, Ross Kedl, Angelo Izzo, Catharine Bosio & Steven Dow. (2006) Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes. The Journal of Immunology 176:12, pages 7335-7345.
Crossref
Crossref
Marina S. Boukhvalova, Gregory A. Prince, Layla Soroush, Dolores C. Harrigan, Stefanie N. Vogel & Jorge C.G. Blanco. (2006) The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 24:23, pages 5027-5035.
Crossref
Crossref
Nima Rezaei. (2006) Therapeutic targeting of pattern-recognition receptors. International Immunopharmacology 6:6, pages 863-869.
Crossref
Crossref
J B Knight, Y Y Huang, S A Halperin, R Anderson, A Morris, A MacMillan, T Jones, D S Burt, G Van Nest & S F Lee. (2006)
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from
Bordetella pertussis
. Clinical and Experimental Immunology 144:3, pages 543-551.
Crossref
Crossref
Liana Tsenova, Ryhor Harbacheuski, Andre L. Moreira, Evette Ellison, Wilfried Dalemans, Mark R. Alderson, Barun Mathema, Steven G. Reed, Yasir A. W. Skeiky & Gilla Kaplan. (2006) Evaluation of the Mtb72F Polyprotein Vaccine in a Rabbit Model of Tuberculous Meningitis. Infection and Immunity 74:4, pages 2392-2401.
Crossref
Crossref
Lisette Bevaart, Marco J.H. Jansen, Martine J. van Vugt, J. Sjef Verbeek, Jan G.J. van de Winkel & Jeanette H.W. Leusen. (2006) The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma. Cancer Research 66:3, pages 1261-1264.
Crossref
Crossref
Y. Li, K. Svehla, N. L. Mathy, G. Voss, J. R. Mascola & R. Wyatt. (2006) Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants. Journal of Virology 80:3, pages 1414-1426.
Crossref
Crossref
V. Salucci, C. Mennuni, F. Calvaruso, R. Cerino, P. Neuner, G. Ciliberto, N. La Monica & E. Scarselli. (2006) CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand. Scandinavian Journal of Immunology 63:1, pages 35-41.
Crossref
Crossref
Jakub K. Simon & Robert Edelman. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
319
342
.
David H. Persing, Patrick McGowan, Jay T. Evans, Christopher Cuff, Sally Mossman, David Johnson & Jory R. Baldridge. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
93
107
.
Jory Baldridge, Kent Myers, David Johnson, David Persing, Christopher Cluff & Robert Hershberg. 2006. Vaccine Adjuvants. Vaccine Adjuvants
235
255
.
Bruce S Thompson, Paula M Chilton, Jon R Ward, Jay T Evans & Thomas C Mitchell. (2005) The low-toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells. Journal of Leukocyte Biology 78:6, pages 1273-1280.
Crossref
Crossref
Vasee S. Moorthy & Filip Dubovsky. 2005. Molecular Approaches to Malaria. Molecular Approaches to Malaria
480
497
.
Marina De Filette, Willy Min Jou, Ashley Birkett, Katie Lyons, Brian Schultz, Anne Tonkyro, Stephanie Resch & Walter Fiers. (2005) Universal influenza A vaccine: Optimization of M2-based constructs. Virology 337:1, pages 149-161.
Crossref
Crossref
Christopher W. Cluff, Jory R. Baldridge, Axel G. Stöver, Jay T. Evans, David A. Johnson, Michael J. Lacy, Valerie G. Clawson, Vonnie M. Yorgensen, Craig L. Johnson, Mark T. Livesay, Robert M. Hershberg & David H. Persing. (2005) Synthetic Toll-Like Receptor 4 Agonists Stimulate Innate Resistance to Infectious Challenge. Infection and Immunity 73:5, pages 3044-3052.
Crossref
Crossref
Bruce A. Green, Ying Zhang, Amy W. Masi, Vicki Barniak, Michael Wetherell, Robert P. Smith, Molakala S. Reddy & Duzhang Zhu. (2005)
PppA, a Surface-Exposed Protein of
Streptococcus pneumoniae
, Elicits Cross-Reactive Antibodies That Reduce Colonization in a Murine Intranasal Immunization and Challenge Model
. Infection and Immunity 73:2, pages 981-989.
Crossref
Crossref
S.B. CohenC. GaskinsM.S. Nasoff. (2005) Generation of a Monoclonal Antibody Agonist to Toll-Like Receptor 4. Hybridoma 24:1, pages 27-35.
Crossref
Crossref
Yanbin Pan, Peter Chefalo, Nancy Nagy, Clifford Harding & Zhongwu Guo. (2005) Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer Vaccines. Journal of Medicinal Chemistry 48:3, pages 875-883.
Crossref
Crossref
Yolanda D. Mahnke, Daniel Speiser, Immanuel F. Luescher, Jean‐Charles Cerottini & Pedro Romero. (2004)
Recent advances in tumour antigen‐specific therapy:
In vivo veritas
. International Journal of Cancer 113:2, pages 173-178.
Crossref
Crossref
Anneke G. Blom & Luuk A. Th. Hilgers. (2004) Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition. Vaccine 23:6, pages 743-754.
Crossref
Crossref
Taff Jones, Sonya Cyr, Francine Allard, Nathalie Bellerose, George H Lowell & David S Burt. (2004) Protollin™: a novel adjuvant for intranasal vaccines. Vaccine 22:27-28, pages 3691-3697.
Crossref
Crossref
Uta G. Lange, Pietro Mastroeni, Jenefer M. Blackwell & Carmel B. Stober. (2004)
DNA-
Salmonella enterica
Serovar Typhimurium Primer-Booster Vaccination Biases towards T Helper 1 Responses and Enhances Protection against
Leishmania major
Infection in Mice
. Infection and Immunity 72:8, pages 4924-4928.
Crossref
Crossref
Julie Véran, Mohamad Mohty, Béatrice Gaugler, Carlo Chiavaroli & Daniel Olive. (2004) OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model. Immunobiology 209:1-2, pages 67-77.
Crossref
Crossref
Richard J. Ulevitch. (2004) Therapeutics targeting the innate immune system. Nature Reviews Immunology 4:7, pages 512-520.
Crossref
Crossref
Yasir A. W. Skeiky, Mark R. Alderson, Pamela J. Ovendale, Jeffrey A. Guderian, Lise Brandt, Davin C. Dillon, Antonio Campos-Neto, Yves Lobet, Wilfried Dalemans, Ian M. Orme & Steven G. Reed. (2004) Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein. The Journal of Immunology 172:12, pages 7618-7628.
Crossref
Crossref
Jay T Evans, Jon R Ward, Jeff Kern & Mark E Johnson. (2004) A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4. Vaccine 22:15-16, pages 1964-1972.
Crossref
Crossref